This site uses cookies to collect activity data and personalize content. By continuing to navigate this site, you agree to allow us to collect information using cookies. Learn more about how we care for your data in our privacy notice.

Accept

Are rotavirus vaccines a good investment for middle-income countries?

Middle-income countries not eligible for support from Gavi, the Vaccine Alliance, have been slow to introduce rotavirus vaccines, largely due to cost concerns. A PATH analysis shows that, in most cases, rotavirus vaccination is likely to be highly cost-effective and beneficial for these countries.

Brief is available in English, French, Russian, and Spanish.

Publication date: July 2021

Available materials

  1. English

    1. Are rotavirus vaccines a good investment for middle-income countries? 85 KB PDF
  2. French

    1. Les vaccins antirotavirus sont-ils un bon investissement pour les pays à revenu intermédiaire ? 73.5 KB PDF
  3. Russian

    1. Целесообразно ли странам со средним уровнем доходов инвестировать в вакцины от ротавирусных инфекций? 165.3 KB PDF
  4. Spanish

    1. ¿Las vacunas contra rotavirus son una buena inversión para países de ingresos medios? 73.3 KB PDF